• Home

  • Documents

  • ccdc.cam.ac.uk › ... › ccdc_drug_poster_mar2020.pdf · 132 Kyprolis Carfilzomib $1.012 Billion...
1

ccdc.cam.ac.uk › ... › ccdc_drug_poster_mar2020.pdf · 132 Kyprolis Carfilzomib $1.012 Billion Oncology 152 Lupron Leuprolide Respiratory Disorders 115 Novoseven Coagulation Factor

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: ccdc.cam.ac.uk › ... › ccdc_drug_poster_mar2020.pdf · 132 Kyprolis Carfilzomib $1.012 Billion Oncology 152 Lupron Leuprolide Respiratory Disorders 115 Novoseven Coagulation Factor

NovoSeven, INN-eptacog alfa (activated)...Rana intervencija pokazala se učinkovitom u liječenju blagih do umjereno teških zglobnih, mišićnih i mukokutanih krvarenja. Mogu se preporučiti

NovoSeven, INN-eptacog alfa (activated)...Rana intervencija pokazala se učinkovitom u liječenju blagih do umjereno teških zglobnih, mišićnih i mukokutanih krvarenja. Mogu se preporučiti

Documents
HEMATOLOGI 20181017 •NYA TYPER AV LÄKEMEDEL o PROTEASOMHÄMMARE. PÅVERKAR BIOLOGISKA SIGNALVÄGAR SOM BETYDELSE FÖR TILLVÄXT OCH ÖVERLEVNAD. (VELCADE, KYPROLIS) o BRUTONS

HEMATOLOGI 20181017 •NYA TYPER AV LÄKEMEDEL o PROTEASOMHÄMMARE. PÅVERKAR BIOLOGISKA SIGNALVÄGAR SOM BETYDELSE FÖR TILLVÄXT OCH ÖVERLEVNAD. (VELCADE, KYPROLIS) o BRUTONS

Documents
REKOMBINOVANI AKTIVIRANI FAKTOR VII (NovoSeven®) Jovan P. Antovic MD, PhD, Medical Advisor Novo Nordisk A/S ROSEE Ljubljana, Slovenia

REKOMBINOVANI AKTIVIRANI FAKTOR VII (NovoSeven®) Jovan P. Antovic MD, PhD, Medical Advisor Novo Nordisk A/S ROSEE Ljubljana, Slovenia

Documents
Hämostase und NovoSeven ® Das neue zellbasierte Modell der Gerinnung und die Wirkungsweise von NovoSeven ® (rFVIIa)

Hämostase und NovoSeven ® Das neue zellbasierte Modell der Gerinnung und die Wirkungsweise von NovoSeven ® (rFVIIa)

Documents
ANEXO I FICHA TÉCNICA O RESUMEN DE LAS ......Kyprolis y dexametasona 56 mg/m 2 45 mg/m2 36 mg/m2 27 mg/m2 a Nota: Los tiempos de perfusión de Kyprolis se mantie nen inalterados durante

ANEXO I FICHA TÉCNICA O RESUMEN DE LAS ......Kyprolis y dexametasona 56 mg/m 2 45 mg/m2 36 mg/m2 27 mg/m2 a Nota: Los tiempos de perfusión de Kyprolis se mantie nen inalterados durante

Documents
Choice Drugs That Require Prior Authorization (PA) Before ... · without Rituxan, Velcade with dexamethasone, Kyprolis with Rituxan and dexamethasone, Imbruvica Rituxan). Differentiated

Choice Drugs That Require Prior Authorization (PA) Before ... · without Rituxan, Velcade with dexamethasone, Kyprolis with Rituxan and dexamethasone, Imbruvica Rituxan). Differentiated

Documents
Entendendo KYPROLIS - myeloma.org.br queando a atividade de complexos de enzimas denominados proteassomas. ... cações para determinar quantos ciclos de tratamento são necessários

Entendendo KYPROLIS - myeloma.org.br queando a atividade de complexos de enzimas denominados proteassomas. ... cações para determinar quantos ciclos de tratamento são necessários

Documents
PRODUCT INFORMATION NOVOSEVEN RT NAME OF THE … · NovoSeven RT Full PI (pi7).docx Page 2 of 19. Pharmacokinetics Healthy subjects . The pharmacokinetics of FVIIa was investigated

PRODUCT INFORMATION NOVOSEVEN RT NAME OF THE … · NovoSeven RT Full PI (pi7).docx Page 2 of 19. Pharmacokinetics Healthy subjects . The pharmacokinetics of FVIIa was investigated

Documents
Congenital Hemophilia with Inhibitors - novosevenrtpro.com · Indications and Usage NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for: • Treatment of bleeding and

Congenital Hemophilia with Inhibitors - novosevenrtpro.com · Indications and Usage NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for: • Treatment of bleeding and

Documents
Multiple Myeloma What is the Therapy of the Future? Rafat … · Velcade, Kyprolis, Ixazomib Immunomodulatory Drugs (IMiDs): Thalomid, Revlimid, Pomalyst HDAC inhibitor: Farydak,

Multiple Myeloma What is the Therapy of the Future? Rafat … · Velcade, Kyprolis, Ixazomib Immunomodulatory Drugs (IMiDs): Thalomid, Revlimid, Pomalyst HDAC inhibitor: Farydak,

Documents
Multiple Myeloma What is the Therapy of the Future? Rafat ... › upload › 13h45RAbonour.pdf · Velcade, Kyprolis, Ixazomib Immunomodulatory Drugs (IMiDs): Thalomid, Revlimid, Pomalyst

Multiple Myeloma What is the Therapy of the Future? Rafat ... › upload › 13h45RAbonour.pdf · Velcade, Kyprolis, Ixazomib Immunomodulatory Drugs (IMiDs): Thalomid, Revlimid, Pomalyst

Documents
NovoSeven, INN-eptacog alfa (activated)...version 6.1 is provided. 26/05/2016 n/a NovoSeven EMA/631639/2019 Page 6/24 C.I.13 - Other variations not specifically covered elsewhere in

NovoSeven, INN-eptacog alfa (activated)...version 6.1 is provided. 26/05/2016 n/a NovoSeven EMA/631639/2019 Page 6/24 C.I.13 - Other variations not specifically covered elsewhere in

Documents
Kyprolis, INN-carfilzomib

Kyprolis, INN-carfilzomib

Documents
CP.PHAR.220 Factor VIIa, Recombinant (NovoSeven RT, SevenFact) · limitations of the coverage documents (e.g., evidence of coverage, certificate of coverage, policy, contract of insurance,

CP.PHAR.220 Factor VIIa, Recombinant (NovoSeven RT, SevenFact) · limitations of the coverage documents (e.g., evidence of coverage, certificate of coverage, policy, contract of insurance,

Documents
Hvað er mergæxli? Einkenni, meðferð og nýjungar í lyfjameðferð · – Sýkingar – Þreyta og slappleiki Kyprolis (carfilzomib) • Skylt Velcade-næsta kynslóð • Gefið

Hvað er mergæxli? Einkenni, meðferð og nýjungar í lyfjameðferð · – Sýkingar – Þreyta og slappleiki Kyprolis (carfilzomib) • Skylt Velcade-næsta kynslóð • Gefið

Documents
Reference ID: 4208179 · dosing as clinically indicated. (2.3, 5.11) Hepatic Toxicity and Hepatic Failure: Monitor liver enzymes regularly. Withhold Kyprolis if suspected. (5.12)

Reference ID: 4208179 · dosing as clinically indicated. (2.3, 5.11) Hepatic Toxicity and Hepatic Failure: Monitor liver enzymes regularly. Withhold Kyprolis if suspected. (5.12)

Documents
ПРИЛОЖЕНИЕ I - ema.europa.eu · След приложение на Kyprolis в цикъл 1, допълнително трябва да се приложат 250 ml до

ПРИЛОЖЕНИЕ I - ema.europa.eu · След приложение на Kyprolis в цикъл 1, допълнително трябва да се приложат 250 ml до

Documents
PRODUCT INFORMATION NOVOSEVEN RT NAME OF THE MEDICINE ... - Novo … · Product Information NovoSeven RT Full PI (pi7).docx Page 1 of 19. PRODUCT INFORMATION . NOVOSEVEN RT NAME OF

PRODUCT INFORMATION NOVOSEVEN RT NAME OF THE MEDICINE ... - Novo … · Product Information NovoSeven RT Full PI (pi7).docx Page 1 of 19. PRODUCT INFORMATION . NOVOSEVEN RT NAME OF

Documents
HIGHLIGHTS OF PRESCRIBING INFORMATION KYPROLIS safely … · dosing as clinically indicated. (2.3, 5.11) Hepatic Toxicity and Hepatic Failure: Monitor liver enzymes regularly. Thrombotic

HIGHLIGHTS OF PRESCRIBING INFORMATION KYPROLIS safely … · dosing as clinically indicated. (2.3, 5.11) Hepatic Toxicity and Hepatic Failure: Monitor liver enzymes regularly. Thrombotic

Documents
Www.ccdc.cam.ac.uk Improving enrichment rates A practical solution to an impractical problem Noel O’Boyle Cambridge Crystallographic Data Centre oboyle@ccdc.cam.ac.uk

Www.ccdc.cam.ac.uk Improving enrichment rates A practical solution to an impractical problem Noel O’Boyle Cambridge Crystallographic Data Centre [email protected]

Documents
NovoSeven, INN-eptacog alfa (activated)

NovoSeven, INN-eptacog alfa (activated)

Documents
HIGHLIGHTSOF PRESCRIBING INFORMATION …/media/amgen/repositorysites/...1 HIGHLIGHTSOF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYPROLIS

HIGHLIGHTSOF PRESCRIBING INFORMATION …/media/amgen/repositorysites/...1 HIGHLIGHTSOF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYPROLIS

Documents
VIÐAUKI I SAMANTEKT Á EIGINLEIKUM LYFS · 3 Kyprolis í samsetningu með lenalidomidi og dexamethasoni Þegar Kyprolis er gefið með lenalidomidi og dexamethasoni er það gefið

VIÐAUKI I SAMANTEKT Á EIGINLEIKUM LYFS · 3 Kyprolis í samsetningu með lenalidomidi og dexamethasoni Þegar Kyprolis er gefið með lenalidomidi og dexamethasoni er það gefið

Documents
Onyx Pharmaceuticals, Inc. KYPROLIS- carfilzomib injection

Onyx Pharmaceuticals, Inc. KYPROLIS- carfilzomib injection

Documents
ANEXO I FICHA TÉCNICA O RESUMEN DE LAS … · NovoSeven 1 mg (50 KUI) NovoSeven es una presentación de polvo y disolvente para solución inyectable que contiene 1 mg de eptacog

ANEXO I FICHA TÉCNICA O RESUMEN DE LAS … · NovoSeven 1 mg (50 KUI) NovoSeven es una presentación de polvo y disolvente para solución inyectable que contiene 1 mg de eptacog

Documents
User Guide and Tutorials - ccdc.cam.ac.uk Mogul User Guide and Tutorials ... 15.1 Tutorial 1: ... Mogul is atheknowledge base of molecular geometry derived from the Cambridge Structural

User Guide and Tutorials - ccdc.cam.ac.uk Mogul User Guide and Tutorials ... 15.1 Tutorial 1: ... Mogul is atheknowledge base of molecular geometry derived from the Cambridge Structural

Documents
Supporting Information · Cambridge, CB2 1EZ, UK (fax: +44 (0)1223 336033; email: deposit@ccdc.cam.ac.uk). S4 Chromatographic methods ... 61.5 (t, 1 C, NCH 2), 124.3

Supporting Information · Cambridge, CB2 1EZ, UK (fax: +44 (0)1223 336033; email: [email protected]). S4 Chromatographic methods ... 61.5 (t, 1 C, NCH 2), 124.3

Documents
NovoSeven® - SFDA · (≥ 1/100 to < 1/10). A higher r isk of arte rial thromboembolic adverse events (5.6% in patients treated with NovoSeven® versus 3.0% in pl ac eb o- r d ins)

NovoSeven® - SFDA · (≥ 1/100 to < 1/10). A higher r isk of arte rial thromboembolic adverse events (5.6% in patients treated with NovoSeven® versus 3.0% in pl ac eb o- r d ins)

Documents
NOVOSEVEN Caroline AUGIER DESC réanimation médicale DES Cardiologie

NOVOSEVEN Caroline AUGIER DESC réanimation médicale DES Cardiologie

Documents
ROTH Conference - d1io3yog0oux5.cloudfront.net · • Average royalty rate on ... Technology and Novel R&D Drive Deal Making Potential Launch ... study of KYPROLIS plus Revlimid

ROTH Conference - d1io3yog0oux5.cloudfront.net · • Average royalty rate on ... Technology and Novel R&D Drive Deal Making Potential Launch ... study of KYPROLIS plus Revlimid

Documents